Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990–2019: A DALY-based analysis of the Global Burden of Disease 2019 study

Sungchul Choi, Beom Kyung Kim, Dong Keon Yon, Seung Won Lee, Han Gyeol Lee, Ho Hyeok Chang, Seoyeon Park, Ai Koyanagi, Louis Jacob, Elena Dragioti, Joaquim Radua, Jae Il Shin, Seung Up Kim, Lee Smith

Clin Mol Hepatol. 2023;29(2):433-452. Published online January 4, 2023

DOI: https://doi.org/10.3350/cmh.2022.0316

View: 1672 Download: 138 Citations: 4

Editorial

The growing burden of non-alcoholic fatty liver disease on mortality

Ju-Yeon Cho, Won Sohn

Clin Mol Hepatol. 2023;29(2):374-376. Published online March 6, 2023

DOI: https://doi.org/10.3350/cmh.2023.0084

View: 620 Download: 30

The current trends in the health burden of primary liver cancer across the globe

Peter Konyn, Aijaz Ahmed, Donghee Kim

Clin Mol Hepatol. 2023;29(2):358-362. Published online March 14, 2023

DOI: https://doi.org/10.3350/cmh.2023.0092

View: 749 Download: 30

The latest global burden of liver cancer: A past and present threat

Joo Hyun Oh, Dae Won Jun

Clin Mol Hepatol. 2023;29(2):355-357. Published online March 9, 2023

DOI: https://doi.org/10.3350/cmh.2023.0070

View: 657 Download: 27

Special topic: Alcoholic liver diseases The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)

Global and regional impacts of alcohol use on public health: Emphasis on alcohol policies

Seung Ha Park, Dong Joon Kim

Clin Mol Hepatol. 2020;26(4):652-661. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0160

View: 3489 Download: 84 Citations: 11

Original Article

Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease

Chansik An, Youn Ah Choi, Dongil Choi, Yong Han Paik, Sang Hoon Ahn, Myeong-Jin Kim, Seung Woon Paik, Kwang-Hyub Han, Mi-Suk Park

Clin Mol Hepatol. 2015;21(3):279-286. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.279

View: 10078 Download: 133 Citations: 53

Review

Cost-of-illness studies: concepts, scopes, and methods

Changik Jo

Clin Mol Hepatol. 2014;20(4):327-337. Published online December 24, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.4.327

View: 21025 Download: 552 Citations: 297

1 |

Viewed By 4174	Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
Viewed By 3581	Subclinical versus advanced forms of alcohol-related liver disease: Need for early detection
Viewed By 2858	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Viewed By 2809	Recent updates on the management of autoimmune hepatitis
Viewed By 2727	Identification of high-risk subjects in nonalcoholic fatty liver disease

Cited By 99	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Cited By 42	Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
Cited By 42	From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
Cited By 40	Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
Cited By 38	The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future

Search